BioRestorative Therapies (BRTX) Other Non Operating Income (2010 - 2025)

BioRestorative Therapies (BRTX) has reported Other Non Operating Income for 14 consecutive years, with $568966.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Other Non Operating Income fell 42.43% year-over-year to $568966.0; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (up 156.53% YoY), and the FY2025 full-year result was $1.1 million, up 643.46% from the prior year.
• Other Non Operating Income fell to $568966.0 in Q4 2025 per BRTX's latest filing, from $612064.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $7.7 million in Q3 2023 and bottomed at -$2.7 million in Q2 2023.
• Historically, Other Non Operating Income has averaged $404540.0 across 4 years, with a median of $335122.5 in 2023.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income surged 44613.73% in 2023, then tumbled 525.52% in 2025.
• Over 4 years, Other Non Operating Income stood at $124372.0 in 2022, then soared by 319.08% to $521224.0 in 2023, then surged by 89.61% to $988316.0 in 2024, then sank by 42.43% to $568966.0 in 2025.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $568966.0, $612064.0, and $574591.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.